Metagenomi Therapeutics (MGX) Cash & Current Investments (2023 - 2026)
Metagenomi Therapeutics' Cash & Current Investments was $120.66 million in Q2 2026, down 41.1% from $204.99 million a year earlier and down 13.9% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Cash & Current Investments (2023 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Metagenomi Therapeutics came in at $160.8 million, down 35.2% from FY2024.
- In earlier years, Cash & Current Investments was $248.31 million in FY2024 (-8.4%) and $271.18 million in FY2023.
- The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q3 2023.
- Compared with a year earlier, Cash & Current Investments has declined for seven straight quarters, with an average decline of 6.1% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q2 2024 (growth of 480.7%); the worst was Q2 2026 (a decline of 41.1%).
- Per Business Quant data, MGX's Cash & Current Investments in the three quarters before Q2 2026 was $140.16 million (Q1 2026), $160.8 million (Q4 2025) and $184.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Metagenomi Therapeutics | 30.49 Mn | -575.25 Mn | - | 120.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 120.66 Mn |
| Mar 31, 2026 | 140.16 Mn |
| Dec 31, 2025 | 160.80 Mn |
| Sep 30, 2025 | 184.11 Mn |
| Jun 30, 2025 | 204.99 Mn |
| Mar 31, 2025 | 225.97 Mn |
| Dec 31, 2024 | 248.31 Mn |
| Sep 30, 2024 | 274.59 Mn |
| Jun 30, 2024 | 299.92 Mn |
| Mar 31, 2024 | 327.41 Mn |
| Dec 31, 2023 | 271.18 Mn |
| Sep 30, 2023 | 101.90 Mn |
| Jun 30, 2023 | 51.65 Mn |
| Mar 31, 2023 | 95.67 Mn |
API Access
Metagenomi Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();